New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
09:37 EDTAFFY, CAP, MSI, MUX, ARIA, ZBRA, PAY, VSTM, PCYC, ONXX, MDR, ALNY, CELG, CENTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Affymax (AFFY) initiated with an Outperform at JMP Securities... Alnylam (ALNY) initiated with an Outperform at JMP Securities... Celgene (CELG) initiated with an Outperform at JMP Securities... DSW (DSW) initiated with a Buy at Sterne Agee... McDermott (MDR) initiated with a Neutral at HSBC... Onyx Pharmaceuticals (ONXX) initiated with an Outperform at JMP Securities... Pharmacyclics (PCYC) initiated with an Outperform at JMP Securities... Verastem (VSTM) initiated with an Outperform at JMP Securities... VeriFone (PAY) initiated with a Hold at Jefferies... sZebra Technologies (ZBRA) initiated with a Market Perform at Wells Fargo... ARIAD (ARIA) initiated with an Outperform at JMP Securities... McEwen Mining (MUX) initiated with a Buy at Stifel Nicolaus... Motorola Solutions (MSI) initiated with an Outperform at Wells Fargo... CAI International (CAP) initiated with an Outperform at Wells Fargo... Central Garden & Pet (CENT) initiated with a Neutral at SunTrust.
News For AFFY;CELG;ALNY;MDR;ONXX;PCYC;VSTM;PAY;ZBRA;ARIA;MUX;MSI;CAP;CENT From The Last 14 Days
Check below for free stories on AFFY;CELG;ALNY;MDR;ONXX;PCYC;VSTM;PAY;ZBRA;ARIA;MUX;MSI;CAP;CENT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 11, 2014
08:28 EDTPCYCPharmacyclics VA contract has ceiling of $3.81B, says JPMorgan
JPMorgan says the Veterans Affairs contract won by Pharmacyclics for Imbruvica has a ceiling price of $3.81B over the entire 5-year period, and that actual sales will depend on the demand the drug generates. The firm notes Imbruvica’s contracted price has been negotiated for year one, and that the VA will either renegotiate the price each year or continue as is. JPMorgan keeps an Overweight rating on shares of Pharmacyclics.
September 10, 2014
14:29 EDTPCYCPharmacyclics Veterans Affairs contract worth up to $17 per share, says Goldman
Today, the U.S. Department of Veterans Affairs awarded Pharmacyclics a contract worth up to $3.8B over the next five years to supply its cancer drug, Imbruvica. Goldman said the contract could be worth up to $17 per share if fully realized and views it as an unexpected windfall for the company.
14:07 EDTPCYCPharmacyclics ibrutinib designated as orphan treatment of follicular lymphoma
Subscribe for More Information
13:11 EDTPCYCPharmacyclics climbs after leukemia drug wins VA contract
Shares of drug maker Pharmacyclics (PCYC) are rallying after a federal government website revealed that the company had won a contract that could be worth up to $3.8B. However, RBC Capital is warning that the deal is not as lucrative as it sounds and will not lead analysts to significantly raise their estimates for the company. WHAT'S NEW: A contract for Phamacyclics' Imbruvica drug, a treatment for chronic lymphocytic leukemia, was disclosed earlier today. The contract from Veterans Affairs, which has an award date of September 4, was revealed in a notice posted today to Federal Business Opportunities website and has a potential value of $3.809B, according to the posting. ANALYST REACTION: In a note to investors today, RBC Capital analyst Michael Yee wrote that the news is positive, but not to the extent that the size of the deal would suggest. Pharmacyclics is indicating that the size of the deal has been significantly misrepresented, Yee reported. Additionally, the order may not be a major surprise to analysts, since it is expected that the government will place orders for oncology drugs, he stated. Although Pharmacyclics is on pace to beat third quarter expectations, the order revealed today is unlikely to lead analysts to significantly raise their estimates, Yee stated. He kept a Sector Perform rating on the shares. PRICE ACTION: In early afternoon trading, Pharmacyclics advanced 5.5% to $125.
12:24 EDTPCYCPharmacyclics VA contract not likely to change estimates, says RBC Capital
Subscribe for More Information
11:22 EDTPAYOptions with decreasing implied volatility
Subscribe for More Information
10:58 EDTPCYCPharmacyclics rises after VA contract award revealed
Shares of drugmaker Pharmacyclics are rising after a contract for its Imbruvica drug that was previously awarded by the Department of Veterans Affairs was disclosed. The contract, which has an award date of September 4, was revealed in an award notice posted today today to Federal Business Opportunities website and has a potential value of $3.809B, according to the posting. Pharmacyclics shares are up 6.5% to $126.35 in morning trading following the circulation of the FBO site posting.
10:51 EDTPCYCPharmacyclics receives contract up to $3B from Department of Veterans Affairs
Subscribe for More Information
10:19 EDTPAYOn Track, USA Technologies rise after Apple Pay seen as positive
Shares of On Track Innovations (OTIV) and USA Technologies (USAT) are moving higher after research firm Northland Capital predicted that both companies would benefit from the launch of Apple's (AAPL) mobile payment system which is based on NFC technology. On Track Innovations sells contactless/NFC readers, while USA Technologies provides products that facilitate electronic payment transactions. WHAT'S NEW: In a note to investors today, Northland Capital analyst Michael Latimore wrote that his discussions with vending operators indicate that Apple Pay will likely provide a major impetus to upgrade payment terminals, benefiting On Track Innovations and USA Technologies. On Track Innovations has gained share in the contactless/NFC reader market and now sells these readers to most of the vending operators in the U.S., Latimore stated. Accelerated adoption of contactless/NFC technology will help increase the number of contactless/NFC readers that are sold, the analyst believes. Meanwhile, US Technologies' cloud services revenue could accelerate as more vending operators deploy NFC readers, Latimore added. The analyst kept Outperform ratings on both stocks. PRICE ACTION: In early trading, On Track Innovations soared 42% to $4.70, while USA Technologies advanced 7% to $2.20. VeriFone (PAY), which sells point of sale electronic payment devices, gained 4% to $36.
September 9, 2014
15:07 EDTPAYPanera Bread announces integration With Apple Pay
Panera Bread (PNRA) announced an integration with Apple Pay, Apple's (AAPL) new mobile payment system for iPhone 6, iPhone 6 Plus, or Apple Watch. Panera Bread will accept Apple Pay in all participating bakery-cafes in the United States once Apple Pay hits the market this fall. In preparation for the rollout, Panera will integrate Apple Pay into the Panera Bread iOS App and install VeriFone (PAY) payment terminals in company owned and franchise bakery-cafes across the United States to support contactless and Near Field Communication payments.
13:52 EDTPAYVeriFone rises after Apple confirms new 'Apple Pay' mobile payment service
VeriFone Systems (PAY), which is engaged in secure electronic payment solutions, is up 1.4% as the Apple (AAPL) event continues.
12:02 EDTPAYOptions with decreasing implied volatility
Options with decreasing implied volatility: KERX CIEN FNSR PAY BKS PVH NAV BYI FTR JOY
09:12 EDTPAYOn The Fly: Pre-market Movers
Subscribe for More Information
08:59 EDTMDRDA Davidson's construction analyst holds an analyst/industry conference call
Subscribe for More Information
07:51 EDTCELGNICE says Abraxane price not justified by limited benefit in pancreatic cancer
Subscribe for More Information
07:12 EDTCAPEuro Pacific to hold a conference
Subscribe for More Information
September 8, 2014
14:19 EDTPAYAlex Meruelo Living Trust reports 5.45% stake in VeriFone
Subscribe for More Information
14:14 EDTMSIMotorola Solutions calls active on wide price movement
Subscribe for More Information
10:42 EDTPAYOptions with decreasing implied volatility
Options with decreasing implied volatility: KERX CONN CIEN INSM FNSR PAY PVH SWY
07:26 EDTCELGMorgan Stanley to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use